Prospective subjective evaluation of swallowing function and dietary pattern in head and neck cancers treated with concomitant chemo-radiation

Journal of Cancer Research and Therapeutics

Volumn 6, Issue 1, 2010, Pages 15-21

  Agarwal, Jaiprakash ^a   Dutta, Debnarayan ^a   Palwe, Vijay ^a   Gupta, Tejpal ^a   Laskar, Sarbani Ghosh ^a   Budrukkar, Ashwini ^a   Murthy, Vedang ^a   Chaturvedi, Pankaj ^a   Pai, Prathemesh ^a   Chaukar, Devendra ^a   D'cruz, A K ^a   Kulkarni, Suyesh ^a   Kulkarni, Aniruddh ^a   Baccher, Gurmit ^a   Shrivastava, Shyam Kishor ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Chemo radiotherapy; Developing countries; Head and neck cancer; Pattern in locally advanced head and neck; Swallowing function

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DYSPHAGIA; EATING HABIT; FEEDING BEHAVIOR; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; MALE; OROPHARYNX CANCER; PERFORMANCE; SMOKING; SQUAMOUS CELL CARCINOMA; SWALLOWING; WEIGHT REDUCTION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; DEGLUTITION; DEGLUTITION DISORDERS; DEVELOPING COUNTRIES; DIET; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INDIA; MALE; MIDDLE AGED; RADIOTHERAPY; SEVERITY OF ILLNESS INDEX;

EID: 77952654197     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.63563     Document Type: Article

References (27)

1. Pignon JP, Bourhis J, Domenge C, Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data: MACH-NC Collaborative Group: Meta-Analysis of Chemotherapy on head and neck cancer. Lancet 2000;355:949-55.
2. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-8.
3. Fung K, Lyden TH, Lee J, Urba SG, Worden F, Eisbruch A, et al. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys 2005;63:1395-9.
4. Budach W, Hehr T, Budach V, Belka C, Dietz K. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer2006;6:28.
5. Nguyen NP, Sallah S, Karlsson U, Antoine JE. Combined chemotherapy and radiation therapy for head and neck malignancies: Quality of life issues. Cancer 2002;94:1131-41.
6. Smith RV, Goldman SY, Beitler JJ, Wadler SS. Decreased short- and longterm swallowing problems with altered radiotherapy dosing used in an organ sparing protocol for advanced pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:831-6.
7. Caudell JJ, Schaner PE, Meredith RF, Locher JL, Nabell LM, Carroll WR, et al. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009;73:410-5.
8. Agarwal JP, Baccher GK, Waghmare CM, Mallick I, Ghosh-Laskar S, Budrukkar A, et al. Factors affecting the quality of voice in the early glottic cancer treated with radiotherapy. Radiother Oncol 2009;90:177-82.
9. Simental AA, Carrau RL. Assessment of swallowing function in patients with head and neck cancer. Curr Oncol Rep 2004;6:162-5.
10. Eisbruch A, Lyden T, Bradford CR, Dawson LA, Haxer MJ, Miller AE, et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and neck cancer. Int J Radiat Oncol Biol Phys 2002;53:23-8.
11. Levendag PC, Teguh DN, Voet P, van der Est H, Noever I, de Kruijf WJ, et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by radiation therapy dose to the superior and middle constrictor muscle: A dose effect relationship. Radiother Oncol 2007;85:64-73.
12. Nguyen NP, Frank C, Moltz CC, Vos P, Smith HJ, Bhamidipati PV, et al. Aspiration rate following chemoradiation for head and neck cancer: An underreported occurrence. Radiother Oncol 2006;80:302-6. (Pubitemid 44397205)
13. Pedruzzi PA, Kowalski LP, Nishimoto IN, Oliveira BV, Tironi F, Ramos GH. Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy. Arch Otolaryngol Head Neck Surg 2008;134:1196-204.
14. List MA, D'Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, et al. The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale: A study of utility and validity. Cancer 1996;77:2294-301.
15. Waxman MJ, Durfee D, Moore M, Morantz RA, Koller W. Nutritional aspects of swallowing function of patients of Parkinson's disease. Nutr Clin Pract 1990;5:196-9.
16. Feng FY, Kim HM, Lyden TH, Haxer MJ, Feng M, Worden FP, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: Early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2007;68:1289-98.
17. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-6.
18. Machtay M, Rosenthal DI, Hershock D, Jones H, Williamson S, Greenberg MJ, et al. Organ preservation therapy using induction plus concurrent chemoradiation for advanced respectable oropharyngeal carcinoma: A University of Pennsylvania phase II trial. J Clin Oncol 2002;20:3964-71.
19. Graner DE, Foote RL, Kasperbauer JL, Stoeckel RE, Okuno SH, Olsen KD, et al. Swallow function in patients before and after intra-arterial chemoradiation. Laryngoscope 2003;113:573-9.
20. Colangelo LA, Logemann JA, Rademaker AW. Tumor size and pretreatment speech and swallowing with resectable tumors. Otolaryngol Head Neck Surg 2000;122:653-61.
21. Eisbruch A, Schwartz M, Rasch C, Vineberg K, Damen E, Van As CJ, et al. Dysphagia and aspiration after chemoradiotherapy for headand-neck cancer: Which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 2004;60:1425-39.
22. Jensen K, Bonde Jensen A, Grau C. The relationship between observerbased toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer: A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires. Radiother Oncol 2006;78:298-5.
23. Salama JK, Stenson KM, List MA, Mell LK, Maccracken E, Cohen EE, et al. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2008;134:1060-5.
24. Connor N P, Cohen SB, Kammer RE, Sullivan PA, Brewer KA, Hong TS, et al. Impact of conventional radiotherapy on health related quality of life and critical functions of head and neck. Int J Radiat Oncol Biol Phys 2006;65:1051-62.
25. Antognoni P, Corvò R, Zerini D, Orecchia R. Altered fractionation radiotherapy in head and neck cancer: Clinical issues and pitfalls of "evidence-based medicine". Tumori 2005;91:30-9.
26. Harrison LB, Zelefsky MJ, Pfister DG, Carper E, Raben A, Kraus DH, et al. Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck 1997;19:169-75.
27. Allal AS, Dulguerov P, Bieri S, Lehmann W, Kurtz JM. Assessment of quality of life in patients treated with accelerated radiotherapy for laryngeal and hypopharyngeal carcinomas. Head Neck 2000;22:288-93.